Sawai Group Holdings Co., Ltd. (TSE: 4887)
Health Care · Pharmaceuticals · JP
¥1,632.00
-1.09% today · -15.9% 1Y
Sawai Group Holdings Co., Ltd. (TSE: 4887) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.19B and employs 3,630 people.
Over the last twelve months the share price has lost 15.9%, trading between 1.55K and 2.45K.
Tweenvest scores Sawai Group Holdings Co., Ltd. across four factors: quality 73/100, value 60/100, growth 11/100, dividend 68/100. Its strongest factor is quality.
4887 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.19B
- Revenue (TTM)
- $1.25B
- P/E
- 19.81
- EPS
- 68.85
- Dividend yield
- 3.43%
- Beta (5Y)
- 0.03
- 52-week high
- ¥2,447.00
- 52-week low
- ¥1,550.50
- Avg volume (3M)
- —
- Shares outstanding
- 115.49M
- Employees
- 3,630
- Next earnings
- —
About Sawai Group Holdings Co., Ltd.
Sawai Group Holdings Co., Ltd., together with its associated companies, focuses on the entire lifecycle of generic medications, from their initial research and development to manufacturing and commercialization. The company's primary operational markets are Japan and the United States. Its diverse portfolio includes generic drugs in numerous dosage forms, such as traditional tablets, orally dissolving tablets, capsules, granular preparations, injectable solutions, transdermal patches, ophthalmic and nasal drops, and syrups. These products address a wide array of medical conditions, encompassing therapeutic areas like cardiovascular health, gastrointestinal disorders, central nervous system ailments, allergies, various cancers, infectious diseases, and hormonal therapies. Key offerings from their extensive product line include atorvastatin, lansoprazole, oseltamivir, pregabalin, and fexofenadine hydrochloride. In Japan, Sawai distributes its generic pharmaceutical products through multiple channels: directly to medical facilities such as hospitals, clinics, and dispensing pharmacies, and indirectly through distributors, retail outlets, and other pharmaceutical manufacturers. For the U.S. market, the company supplies its products to pharmaceutical wholesalers. Sawai Group Holdings Co., Ltd. was established in 1929 and is based in Osaka, Japan.
- ISIN
- JP3323040000
- Founded
- 1929
- Listed since
- Apr 1, 2021
- Exchange
- The Tokyo Stock Exchange
- Currency
- JPY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.06T | $1,189.41 | -3.59% |
| Johnson & JohnsonNYSE: JNJ | $650.67B | $270.00 | -1.15% |
| Merck & Co., Inc.NYSE: MRK | $377.72B | $153.10 | -2.14% |
| Roche Holding AGSWX: ROP | $365.10B | CHF368.30 | -1.47% |
| Novartis AGSWX: NOVN | $300.07B | CHF127.18 | -0.90% |
| AstraZeneca PLCLSE: AZN | $257.89B | £122.34 | -1.94% |
| Novo Nordisk A/SCPSE: NOVO B | $210.23B | Dkr304.95 | -0.93% |
| Pfizer Inc.NYSE: PFE | $161.30B | $28.30 | -0.95% |
Figures last refreshed Aug 18, 2026.